Outcomes of intra-articular corticosteroid injections for adolescents with hip pain. by Tangtiphaiboontana, Jennifer et al.
UCSF
UC San Francisco Previously Published Works
Title
Outcomes of intra-articular corticosteroid injections for adolescents with hip pain.
Permalink
https://escholarship.org/uc/item/6bj887ng
Journal
Journal of hip preservation surgery, 5(1)
ISSN
2054-8397
Authors
Tangtiphaiboontana, Jennifer
Zhang, Alan L
Pandya, Nirav K
Publication Date
2018
DOI
10.1093/jhps/hnx027
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Outcomes of intra-articular corticosteroid injections
for adolescents with hip pain
Jennifer Tangtiphaiboontana1, Alan L. Zhang2* and Nirav K. Pandya3
1Department of Orthopaedic Surgery, University of California, San Francisco (UCSF), 500 Parnassus Avenue, MU-302 West, San Francisco, CA 94143, USA,
2Department of Orthopaedic Surgery, University of California, San Francisco (UCSF), 1500 Owens Street, San Francisco, CA 94158, USA and
3Department of Orthopaedic Surgery, UCSF Benioff Children’s Hospital of Oakland, 744 52nd Street, Oakland, CA 94609, USA
*Correspondence to: A. L. Zhang.
Submitted 8 March 2017; Revised 1 May 2017; revised version accepted 19 June 2017
ABSTRACT
Intra-articular injection of corticosteroid and anesthetic (CSI) is a useful diagnostic tool for hip pain secondary
to labral tears or femoroacetabular impingement (FAI). However, the effectiveness of CSI as a stand-alone treat-
ment for hip pain in adolescents is unknown. The purpose of this study is to evaluate the use of CSI for the treat-
ment of hip pain and determine factors that may affect outcomes after injection. Retrospective analysis of
18 patients and 19 hips that underwent fluoroscopic guided hip injection for the treatment of pain at a single in-
stitution from 2012 to 2015 was carried out in this study. Mean age at the time of injection was 15.1 years (range
13–17) with mean follow-up of 29.4 months. Fifty-two percent (10/19 hips) went on to surgery after the injec-
tion. Average time to surgical conversion was 12.8months after CSI. Cam or pincer morphologies were present
in 90% (9/10 hips) of the operative group. Patients with FAI were more likely to need surgery than patients with-
out bony abnormalities (RR¼ 10, 95% CI 1.6–64.2, P¼ 0.0001). There was no difference in the presence of la-
bral tears in the operative and non-operative groups (100% versus 89%, P¼ 0.47). For adolescents without bony
abnormalities, 90% improved with CSI alone and did not require further treatment within 2.4 years. Fluoroscopic
guided corticosteroid hip injection may have limited efficacy for the treatment of hip pain secondary to FAI in
adolescents. However, for patients without osseous deformity, CSI may offer prolonged improvement of symp-
toms even in the presence of labral tears.
INTRODUCTION
There has been an increase in diagnosis and treatment of
hip injuries among adolescents. Treatment for pediatric
hip disorders such as dysplasia, perthes and slipped capital
femoral epiphysis (SCFE) have been well established;
however, the diagnosis and treatment of conditions such as
femoroacetabular impingement (FAI) and labral tears has
limited long-term evidence [1, 2]. Hip pain secondary to
FAI and/or labral tear has been described as a common
phenomenon among adolescent athletes [1, 2]. The
workup and diagnosis typically includes a physical exam
and radiographic evaluation with X-rays and/or magnetic
resonance imaging (MRI). Initial treatment of acute hip
pain includes activity modification and physical therapy to
increase flexibility, strength and balance, which have been
well established in the adult population [3, 4]. When these
interventions fail, an intra-articular injection of corticoster-
oid and anesthetic (CSI) is considered.
Intra-articular injection of CSI under fluoroscopic guidance
is a useful tool for the localization of pain secondary to an
intra-articular process. A study by Byrd and Jones demon-
strated that an improvement in pain after an injection is a
reliable indicator of intra-articular pathology as 90% of pa-
tients had abnormalities on MRI, MRA or arthroscopy [5].
Studies evaluating the therapeutic role of CSI in adults
have demonstrated varying results. Hunt et al. demon-
strated pain relief in 6 out of the 18 patients with mild FAI
at 12months whereas Krych et al. found a mean duration
of significant pain relief at 9.8 days with only 6% of pa-
tients who had relief up to 6 weeks [3, 6].
These studies support a trial of conservative treatment
and CSI for therapeutic purposes; however, conservative
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treatment appears to be most effective in those who have
lower baseline activity scores and those who can accommo-
date activity modification [3, 6, 7]. Although the use of
CSI for localization for intra-articular pathology has been
well documented, the effectiveness and duration of im-
provement of CSI as a stand-alone treatment for hip pain
in adolescent patients is unknown. The purpose of this
study is to evaluate the use of intra-articular CSI for the
treatment of hip pain in adolescents and determine factors
that may affect outcomes after injection. We hypothesize
that there is limited prolonged therapeutic effects from
CSI in the adolescent population.
MATERIALS AND METHODS
A retrospective chart review of 1600 patients who under-
went surgical intervention at a single institution from 2012
to 2015 was performed. Twenty-seven patients who under-
went fluoroscopic guided hip injection with corticosteroid
for the treatment of hip pain were identified. Those with
less than 12months of follow-up and age>18 years were
excluded from the study. Five patients had a history of
prior hip surgery and were also excluded. A total of 19 hips
in 18 patients (15 females, 4 males) were included in the
analysis. All patients were referred to physical therapy and
completed a 6-week course prior to the injection.
All hip injections were performed in the operating
room by the senior author and anesthesia was used for pa-
tient comfort. Physical examination of the hip and range of
motion (ROM) was assessed under anesthesia. Using an
entry point over the superior border of the greater trochan-
ter and 1 cm anterior to it, an 18-gauge spinal needle was
placed into the hip joint under fluoroscopic guidance. Two
milliliters of half-strength Conray dye were injected to con-
firm intra-articular placement of the needle. The dye was
aspirated out of the joint and the hip was injected with a
mixture of 40mg of kenalog, 2ml of 1% lidocaine and 2ml
of 0.125% bupivacaine. All patients were referred to phys-
ical therapy after receiving the injection.
The primary outcome of the study was conversion to
surgical intervention. Other data collected from the med-
ical records for secondary analysis included patient demo-
graphics, intraoperative hip ROM, and radiographic
findings on X-ray and MRI. The lateral center edge angle
(LCEA) and a angle were measured on all available X-rays.
The presence of cam morphology was defined as an a
angle>55 on X-ray [8, 9]. Pincer morphology was
defined as a LCEA> 40 or the presence of a crossover or
ischial spine sign [10–12]. MRIs were also reviewed for
intra-articular pathologies such as labral tears or chondral
labral separation.
IRB approval was obtained for this study. Statistical ana-
lysis was performed using STATA (Version 12, StataCorp,
College Station, TX, USA). The presence of labral pathology
and bony abnormalities, defined as the radiographic evidence
of dysplasia or CAM/pincer morphology, were compared
between patients who require surgical intervention and those
whose hip pain was sufficiently treated with the injection
alone using v2 test and Fisher’s exact test, when appropriate.
Continuous variables including means for age, a angle and
LCEA angle were compared using Student’s t test. Statistical
significance was defined as a P values<0.05.
RESULTS
The mean age at time of injection was 15.1 years (range
13–17). Thirteen patients reported participation in sports.
At a mean follow-up of 29.4months (range 12–
52months), 52.6% (10/19 hips) of the cohort went on to
surgical intervention after the injection. Of the 10 hips that
underwent surgery, the average time between the injection
and surgical treatment was 12.8months (range 2–
36months) (Table I). Nine hips were treated arthroscopi-
cally while one was treated with open labral repair and ace-
tabuloplasty of the anterior wall. There was no difference
in gender, age, history of prior hip surgery or hip ROM be-
tween patients that underwent surgery and patients that
improved with CSI alone (Table II).
Diagnostic imaging revealed osseous deformities in nine
hips consistent with FAI (cam or pincer morphology). Pre-
injection MR imaging demonstrated the presence of labral
tears in 94.7% (18/19 hips) of the cohort. A majority
(88.9%) of tears involved the anterior-superior aspect of
the labrum. Mean a angle was 55.4 and 44 in the opera-
tive and non-operative groups, respectively (P¼ 0.0001).
Mean LCEA between both groups was 37 and 31.2, re-
spectively (P¼ 0.02) (Table II). Cam or pincer morph-
ology consistent with FAI were present in 90% (9/10
hips) of the operative group. There were no osseous
deformities in the non-operative group. Patients with osse-
ous deformities were more likely to need surgical interven-
tion than patients without FAI (RR¼ 10, 95% CI 1.6–64.2,
P¼ 0.0001). Of the remaining 10 patients without osseous
deformities, 90% improved with CSI alone even in the
presence of a labral tear and did not require further treat-
ment. There was no statistically significant difference in
the presence of a labral tear between those that required
surgery compared with those who were treated with an in-
jection alone (10 hips versus 8 hips, P¼ 0.47).
DISCUSSION
The results of our study suggest that fluoroscopic guided
corticosteroid hip injection may have limited efficacy for
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Table I. Demographics and imaging findings of individual patients in the surgical group
Patient
number
Gender Age at
injection
(years)
Sport Affected
hip
Bony
deformity
a angle
(degrees)
LCEA
(degrees)
Other X-ray
findings
Labral tear Time to
surgery
(months)
1 F 13 Soccer, basket-
ball, volley-
ball, baseball
Left Yes 49 50 Protrusio Anterior 8
2 F 13 Softball,
basketball
Left Yes 58 38 Anterior 13
3 F 17 Soccer Right Yes 47 38 Acetabular
Retroversion
Anterior 10
4 F 16 Right Yes 56 39 Acetabular
Retroversion
Anterior-Superior 5
5 F 17 Crew Right Yes 60 40 Anterior-Superior 2
6 M 15 Soccer Right Yes 57 29 Anterior
7 M 17 Right No 45 33 Posterior 4
8 M 13 Football Left Yes 64 31 Anterior-Superior 3
9 F 14 Dance Right Yes 56 36 Anterior-Superior 36
10 F 13 Right Yes 62 36 Posterior 34
LCEA, lateral center edge angle.
Table II. Summary of demographic and radiographic findings in the surgical and non-surgical groups
Surgery (n¼10) No surgery (n¼9) P-value
Age, mean (SD) years 14.8 (1.8) 15.4 (1.1) 0.37
Gender 0.58
Female 7 8
Male 3 1
Hip range of motion, mean (SD) degrees
Flexion 117.8 (3.6) 119.4 (1.7) 0.23
Internal rotation 41.1 (4.9) 49.4 (10.7) 0.05
External rotation 58.3 (10) 63.9 (3.3) 0.13
Bony abnormality 9 0 0.0001
Mixed cam/pincher 2 0
Cam only 5 0
Pincher only 2 0
No bony abnormality 1 9
a angle, mean (SD) degrees 55.4 (6.4) 44.0 (4.8) 0.0009
LCEA, mean (SD) degrees 37 (5.8) 31.2 (2.9) 0.02
Labral tear 10 8 0.47
LCEA, lateral center edge angle; SD, standard deviation.
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therapeutic treatment of adolescent hip pain secondary to
osseous deformities such as FAI. Of the 9 hips with bony
abnormalities, all required surgical intervention within
12.8months of injection. However, for adolescents without
bony abnormalities, 90% (9/10 hips) improved with CSI
alone and did not require further treatment within
2.4 years even if a labral tear was present on MRI/MRA.
While the diagnostic role of intra-articular hip injection is
well understood, in a pediatric/adolescent population, this
is often performed under anesthesia or sedation for patient
comfort. To our knowledge, this study is the first to evalu-
ate the efficacy of CSI for the treatment of adolescent hip
pain.
There has been an increase in pediatric and adolescent
hip pain in the population, which may be attributed to an
increased participation in athletic activities. In this specific
group of patients, bony morphology such cam and pincer
morphologies and labral tears are one of the most common
causes of pain. Several studies have demonstrated an asso-
ciation of cam morphology and sports activities in child-
hood [13, 14]. A study by Siebenrock et al. reported a
10-fold increase of cam-type impingement in athletes com-
pared to age match controls who did not participate in
sports [14]. One of the proposed mechanisms for the in-
crease of cam impingement in adolescent athletes includes
repetitive stress demands during period of growth that may
alter the development of the proximal femur and lead to
cam formation [15–17]. Further investigation of treatment
options such as physical therapy, corticosteroid injection,
or surgery for these patients is warranted.
The patients in our study with FAI had a significant rate
of treatment failure with the injection and eventually
required surgery. Surgical indications and treatment of hip
pain in young patients has continued to evolve with the ad-
vancement and improvement in hip arthroscopy tech-
niques. Clohisy et al. proposed surgical treatment
guidelines of hip pain in young adults based on the eti-
ology of pain [18]. Those with intra-articular disorders
without structural abnormalities such as labral tears, chon-
dral defect, or synovitis could be treated with hip arthros-
copy. Patients with structural abnormalities such as
dysplasia, SCFE, and FAI are treated with osteotomies or
osteoplasty via arthroscopic or open techniques depending
on the severity of the deformity. Chen et al. demonstrated
good results with osteoplasty in treatment of cam mor-
phologies in patients with a history of SCFE [19]. There
have been several studies demonstrating the safety of hip
arthroscopy in the pediatric population with encouraging
results of surgical treatment of FAI [20–23].
Despite the high rate of treatment failure with injections
in our cohort, there was a group of patients with labral
tears in the absence of FAI who did well with injections.
This finding suggests that this specific population may be
adequately treated with conservative management and may
prevent or delay the need for surgery. While there is a high
rate of labral tears associated with FAI [24], there have
been a number of studies evaluating the rate of asymptom-
atic labral tears in the population. Prior studies have re-
ported an 85.7 and 56% prevalence rate of labral tears in
asymptomatic military personnel and professional/collegi-
ate level ice hockey players, respectively [25, 26]. Among
young, recreationally active adults, the prevalence rate was
lower at 38.6% [27]. There has been one study reporting a
prevalence of 1.4% of asymptomatic labral tears in chil-
dren; however, the patients in this population were those
with chronic medical conditions and low physical demands
[28]. None of the patients with isolated labral tears in our
study reported a traumatic episode or injury event; how-
ever, a majority of patients participated in sports activities
and may have experienced microtrauma that resulted in la-
bral tears detected on MRI/MRA.
Finally, repeated use of CSI under anesthesia may ac-
crue local and systemic reactions. Systemic effects of intra-
articular steroid injections include a transient suppression
of the hypothalamic–pituitary–adrenal axis and cortisol lev-
els, increase in blood glucose levels, decrease in markers of
bone turnover and formation, potential growth suppres-
sion, subcutaneous lipoatrophy, and dermatologic changes
such as flushing, acne, and pigmentary changes at the injec-
tion site [29, 30]. Several studies have also demonstrated
the injury to chondrocytes with local anesthetic. Piper et al.
summarized the chondrotoxic effects of bupivacaine, lido-
caine, and ropivacaine on human articular cartilage [31].
Another study by Farkas et al. demonstrated a synergistic
effect of local anesthetic and steroids on chondrocyte
apoptosis with the combination of betamethasone and
ropivacaine being the most cytotoxic [32]. Exposure to
general anesthesia may also have neurocognitive conse-
quences such as development and behavioral disorders;
however, these findings have been limited to patients with
early anesthetic exposure (age<36months) and animal
studies [33–35]. The results of our study indicate that
there is limited therapeutic benefit from CSI in the adoles-
cent population with osseous hip deformity; therefore, re-
peated CSI in this population may incur greater risks than
benefits.
Our study has several limitations. The first limitation is
the small sample size of our cohort which limits our statis-
tical power and is likely underpowered. While our study
may have been able to detect differences in some out-
comes, we were unable to perform a power analysis as
there are no prior studies evaluating the efficacy of
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intra-articular injections as a standalone treatment for hip
pain in the adolescent population. The data collection and
analyses were also limited to the information available in
the medical records as this was a retrospective study. The
study also lacked important clinical results such as patient
reported outcomes scores. While we were able to report
and analyze objective data such as hip ROM and conver-
sion to surgery, we were unable to determine the extent of
pain relief or quality improvement with the injections.
Finally, there may be an inherent bias towards surgical
treatment in patients with bony morphology as they may
feel that injections would not be able to treat this.
However, these adolescent patients and families were very
conservative with respect to their treatments and therefore
all underwent CSI while under anesthesia with the hopes
of avoiding further surgery. Despite these limitations, this
study offers initial pilot data with over 2-year follow-up in
adolescent patients. The results provided here can be used
to launch larger analyses for more in-depth investigations.
Our data suggest that CSI may not be as effective for
patients with hip pain in the presence of osseous deform-
ities but may provide prolonged symptom improvement in
those without osseous deformities, even in the presence of
a labral tear seen on MRI. Additional studies are required
to further investigate the role of injections, especially
among patients with labral tears alone, to determine the
therapeutic effects of intra-articular injections.
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